For a complete list of the peptide therapies we offer and to discuss which options may be appropriate for your wellness goals, give us a call
Week 1-2: initial adjustment Mild nausea is the most common early side effect
Altered Mental Behavior - Clinical trials with patients undergoing weight management and using Semaglutide and other weight management products have reported showing signs of depression, suicidal thoughts, unusual mood alterations, and worsening of the present depression
A phase 3 trial of a higher-dose CagriSema formulation at 2.4/7.2 mg is planned for initiation in the second half of 2026, and the REDEFINE 11 trial, exploring CagriSemas full weight-loss potential, is expected to report data in the first half of 2027
Are There Any Noted Similarities Between L-Carnitine and L-Carnosine
As awareness of oxidative stress, environmental toxin exposure, and cellular aging mechanisms has expanded, demand for more effective antioxidant delivery systems has intensified correspondingly